1. Home
  2. ABL vs SIGA Comparison

ABL vs SIGA Comparison

Compare ABL & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABL
  • SIGA
  • Stock Information
  • Founded
  • ABL 2004
  • SIGA 1995
  • Country
  • ABL United States
  • SIGA United States
  • Employees
  • ABL N/A
  • SIGA N/A
  • Industry
  • ABL Investment Managers
  • SIGA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ABL Finance
  • SIGA Health Care
  • Exchange
  • ABL Nasdaq
  • SIGA Nasdaq
  • Market Cap
  • ABL 546.8M
  • SIGA 594.3M
  • IPO Year
  • ABL N/A
  • SIGA 1997
  • Fundamental
  • Price
  • ABL $5.48
  • SIGA $8.16
  • Analyst Decision
  • ABL Strong Buy
  • SIGA
  • Analyst Count
  • ABL 3
  • SIGA 0
  • Target Price
  • ABL $12.50
  • SIGA N/A
  • AVG Volume (30 Days)
  • ABL 643.1K
  • SIGA 390.2K
  • Earning Date
  • ABL 11-06-2025
  • SIGA 11-06-2025
  • Dividend Yield
  • ABL N/A
  • SIGA 7.14%
  • EPS Growth
  • ABL N/A
  • SIGA N/A
  • EPS
  • ABL N/A
  • SIGA 1.14
  • Revenue
  • ABL $161,724,466.00
  • SIGA $179,639,422.00
  • Revenue This Year
  • ABL $79.57
  • SIGA N/A
  • Revenue Next Year
  • ABL $21.05
  • SIGA $115.06
  • P/E Ratio
  • ABL N/A
  • SIGA $7.37
  • Revenue Growth
  • ABL 69.56
  • SIGA 3.86
  • 52 Week Low
  • ABL $4.60
  • SIGA $4.95
  • 52 Week High
  • ABL $9.69
  • SIGA $9.62
  • Technical
  • Relative Strength Index (RSI)
  • ABL 40.16
  • SIGA 42.88
  • Support Level
  • ABL $5.36
  • SIGA $8.22
  • Resistance Level
  • ABL $6.18
  • SIGA $8.55
  • Average True Range (ATR)
  • ABL 0.34
  • SIGA 0.30
  • MACD
  • ABL -0.02
  • SIGA -0.04
  • Stochastic Oscillator
  • ABL 14.63
  • SIGA 11.97

About ABL Abacus Life Inc.

Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The Company organizes its business into five reportable segments Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. Its operations are confined to the United States.

About SIGA SIGA Technologies Inc.

SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.

Share on Social Networks: